Researchers at Bacterin have developed a rifampin-and minocycline-containing coating aimed at inhibiting microbial contamination of the implant. “Our testing has shown that the coating inhibits infection progression in a rabbit model of pin track infection and significantly aids orthopedic hardware in maintaining anchoring strength,” said Mark Schallenberger, MS, the lead research scientist for the project and presenter of the findings at the meeting.
The antimicrobial coating has not yet received clearance from the U.S. Food and Drug Administration.
More articles on devices:
Medical start-up fundraising soars 28% in 2014 so far — 5 quick facts
10 things to know about Exactech’s 3Q financial report — Net income drops 6%
Aurora Spine, Sentio sign distribution agreement for nerve mapping system
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
